SE0302324D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0302324D0 SE0302324D0 SE0302324A SE0302324A SE0302324D0 SE 0302324 D0 SE0302324 D0 SE 0302324D0 SE 0302324 A SE0302324 A SE 0302324A SE 0302324 A SE0302324 A SE 0302324A SE 0302324 D0 SE0302324 D0 SE 0302324D0
- Authority
- SE
- Sweden
- Prior art keywords
- sup
- novel compounds
- compounds
- racemates
- tautomers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0302324A SE0302324D0 (sv) | 2003-08-28 | 2003-08-28 | Novel compounds |
CNB200480024988XA CN100424080C (zh) | 2003-08-28 | 2004-08-25 | 作为嗜中性白细胞弹性蛋白酶抑制剂的喹喔啉衍生物及它们的用途 |
EP04775331A EP1660460B1 (en) | 2003-08-28 | 2004-08-25 | Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
ES04775331T ES2302033T3 (es) | 2003-08-28 | 2004-08-25 | Derivados de quinozalina como inhibidores de la elastasa de los neurofilos y su utilizacion. |
JP2006524602A JP2007504127A (ja) | 2003-08-28 | 2004-08-25 | 好中球エラスターゼ阻害剤としてのキノキサリン誘導体およびその使用 |
DE602004012758T DE602004012758T2 (de) | 2003-08-28 | 2004-08-25 | Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung |
PCT/SE2004/001225 WO2005021512A1 (en) | 2003-08-28 | 2004-08-25 | Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
AT04775331T ATE390415T1 (de) | 2003-08-28 | 2004-08-25 | Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung |
US10/569,923 US20060270666A1 (en) | 2003-08-28 | 2004-08-25 | Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
HK06109473A HK1089163A1 (en) | 2003-08-28 | 2006-08-25 | Quinoxaline derivatives as neutrophil elastase inhibitors and their use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0302324A SE0302324D0 (sv) | 2003-08-28 | 2003-08-28 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0302324D0 true SE0302324D0 (sv) | 2003-08-28 |
Family
ID=28673218
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0302324A SE0302324D0 (sv) | 2003-08-28 | 2003-08-28 | Novel compounds |
Country Status (10)
Country | Link |
---|---|
US (1) | US20060270666A1 (xx) |
EP (1) | EP1660460B1 (xx) |
JP (1) | JP2007504127A (xx) |
CN (1) | CN100424080C (xx) |
AT (1) | ATE390415T1 (xx) |
DE (1) | DE602004012758T2 (xx) |
ES (1) | ES2302033T3 (xx) |
HK (1) | HK1089163A1 (xx) |
SE (1) | SE0302324D0 (xx) |
WO (1) | WO2005021512A1 (xx) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200500341A (en) * | 2002-11-12 | 2005-01-01 | Astrazeneca Ab | Novel compounds |
SE0302323D0 (sv) * | 2003-08-28 | 2003-08-28 | Astrazeneca Ab | Novel compounds |
SE0302486D0 (sv) | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
TW200700392A (en) * | 2005-03-16 | 2007-01-01 | Astrazeneca Ab | Novel compounds |
GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
CA2618089A1 (en) | 2005-08-08 | 2007-02-15 | Argenta Discovery Ltd. | Bicyclo[2.2.]hept-7-ylamine derivatives and their uses |
GB0605469D0 (en) * | 2006-03-17 | 2006-04-26 | Argenta Discovery Ltd | Multimers of heterocyclic compounds and their use |
TW200808763A (en) | 2006-05-08 | 2008-02-16 | Astrazeneca Ab | Novel compounds I |
TW200808771A (en) * | 2006-05-08 | 2008-02-16 | Astrazeneca Ab | Novel compounds II |
EA017807B1 (ru) * | 2007-08-01 | 2013-03-29 | Кумиай Кемикал Индастри Ко., Лтд. | Производное оксопиразина и гербицид |
EP2217591A4 (en) | 2007-11-06 | 2011-10-26 | Astrazeneca Ab | CERTAIN 2-PYRAZINONE DERIVATIVES AND THEIR USE AS NEUTROPHILES ELASTASE INHIBITORS |
DE102007062550A1 (de) * | 2007-12-20 | 2009-06-25 | Westfälische Wilhelms-Universität Münster Körperschaft des öffentlichen Rechts | Perhydrochinoxalin-Derivate |
WO2010022281A1 (en) * | 2008-08-20 | 2010-02-25 | Greystone Pharmaceuticals, Inc. | Methods for using human neutrophil elastase as an indicator of active wound infection |
JO3265B1 (ar) | 2008-12-09 | 2018-09-16 | Novartis Ag | مثبطات بيريديلوكسى اندولات vegf-r2 واستخدامها لعلاج المرض |
TW201036957A (en) * | 2009-02-20 | 2010-10-16 | Astrazeneca Ab | Novel salt 628 |
CA2764775C (en) * | 2009-06-26 | 2019-02-26 | University Of Florida Research Foundation, Inc. | Rapid bed-side measurement of neutrophil elastase activity in biological fluids |
KR20120099639A (ko) * | 2009-10-02 | 2012-09-11 | 아스트라제네카 아베 | 호중구 엘라스타제의 억제제로서 사용되는 2-피리돈 화합물 |
GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
US9115093B2 (en) * | 2013-03-04 | 2015-08-25 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
USRE47493E1 (en) | 2014-02-20 | 2019-07-09 | Boehringer Ingelheim International Gmbh | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity |
WO2019152977A2 (en) | 2018-02-05 | 2019-08-08 | Bio-Rad Laboratories, Inc. | Chromatography resin having an anionic exchange-hydrophobic mixed mode ligand |
EP4031138A1 (en) | 2019-09-17 | 2022-07-27 | Mereo Biopharma 4 Limited | Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease |
MX2022012942A (es) | 2020-04-16 | 2023-01-11 | Mereo Biopharma 4 Ltd | Metodos que involucran el inhibidor de la elastasa de neutrofilo alvelestat para el tratamiento de enfermedades respiratorias mediadas por deficiencia de alfa-1 antitripsina. |
KR102600176B1 (ko) * | 2021-10-18 | 2023-11-10 | 주식회사 사피엔스바이오 | 신규한 화합물 및 이를 포함하는 약학적 조성물 |
IL312002A (en) | 2021-10-20 | 2024-06-01 | Mereo Biopharma 4 Ltd | Neutrophil elastase inhibitors for use in the treatment of fibrosis |
CN115109066B (zh) * | 2022-06-30 | 2023-04-07 | 武汉工程大学 | 一种大斯托克斯位移检测弹性蛋白酶的荧光探针及其制备方法与应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2706977A1 (de) * | 1977-02-18 | 1978-08-24 | Hoechst Ag | Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung |
EP0008864A1 (en) * | 1978-08-15 | 1980-03-19 | FISONS plc | Pyridopyrazine and quinoxaline derivatives, processes for their preparation, and pharmaceutical compositions containing them |
ZA794209B (en) * | 1978-08-15 | 1980-07-30 | Fisons Ltd | Pharmaceutically active heterocyclic compounds |
IL89043A0 (en) * | 1988-01-27 | 1989-08-15 | Lilly Co Eli | Antibody conjugates |
JPH02152966A (ja) * | 1988-12-05 | 1990-06-12 | Otsuka Pharmaceut Co Ltd | 4−ヒドロキシカルボスチリル誘導体 |
AU9049391A (en) * | 1990-12-20 | 1992-07-22 | Warner-Lambert Company | 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity |
US5521179A (en) * | 1991-04-18 | 1996-05-28 | Zeneca Limited | Heterocyclic amides |
US5441960A (en) * | 1992-04-16 | 1995-08-15 | Zeneca Limited | 1-pyrimidinylacetamide human leukocyte elastate inhibitors |
US6949571B2 (en) * | 2000-06-12 | 2005-09-27 | Eisai Co., Ltd. | 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
TWI287004B (en) * | 2000-12-28 | 2007-09-21 | Shionogi & Co | A pyridone derivative having an affinity effect for cannabinoid 2 type receptor |
SE0302323D0 (sv) * | 2003-08-28 | 2003-08-28 | Astrazeneca Ab | Novel compounds |
-
2003
- 2003-08-28 SE SE0302324A patent/SE0302324D0/xx unknown
-
2004
- 2004-08-25 DE DE602004012758T patent/DE602004012758T2/de not_active Expired - Fee Related
- 2004-08-25 AT AT04775331T patent/ATE390415T1/de not_active IP Right Cessation
- 2004-08-25 US US10/569,923 patent/US20060270666A1/en not_active Abandoned
- 2004-08-25 JP JP2006524602A patent/JP2007504127A/ja active Pending
- 2004-08-25 ES ES04775331T patent/ES2302033T3/es active Active
- 2004-08-25 WO PCT/SE2004/001225 patent/WO2005021512A1/en active Application Filing
- 2004-08-25 CN CNB200480024988XA patent/CN100424080C/zh not_active Expired - Fee Related
- 2004-08-25 EP EP04775331A patent/EP1660460B1/en not_active Not-in-force
-
2006
- 2006-08-25 HK HK06109473A patent/HK1089163A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20060270666A1 (en) | 2006-11-30 |
HK1089163A1 (en) | 2006-11-24 |
CN1845909A (zh) | 2006-10-11 |
ATE390415T1 (de) | 2008-04-15 |
DE602004012758D1 (de) | 2008-05-08 |
DE602004012758T2 (de) | 2009-04-09 |
WO2005021512A1 (en) | 2005-03-10 |
EP1660460B1 (en) | 2008-03-26 |
JP2007504127A (ja) | 2007-03-01 |
EP1660460A1 (en) | 2006-05-31 |
ES2302033T3 (es) | 2008-07-01 |
CN100424080C (zh) | 2008-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0302487D0 (sv) | Novel compounds | |
SE0302324D0 (sv) | Novel compounds | |
SE0302323D0 (sv) | Novel compounds | |
SE0302486D0 (sv) | Novel compounds | |
TW200500341A (en) | Novel compounds | |
MX2007009372A (es) | Nuevos compuestos ii derivados de 2-piridina como inhibidores de elastasa neutrofila. | |
SE0202463D0 (sv) | Novel compounds | |
ECSP044992A (es) | Inhibidores de la alquín-aril fosfodiesterasa-4 | |
NO20044995L (no) | Heterosykliske forbindelser | |
SE0302139D0 (sv) | Novel compounds | |
SE0203304D0 (sv) | Novel Coumpounds | |
SE0102055D0 (sv) | New Compounds | |
SE0302756D0 (sv) | Novel Compounds | |
SE0303280D0 (sv) | Novel compounds | |
SE0202461D0 (sv) | Novel compounds | |
SE0102641D0 (sv) | Novel compounds | |
DE60103034D1 (de) | Neue phenylheteroalkylamin-derivate | |
SE0403118D0 (sv) | New compounds 2 | |
SE9904676D0 (sv) | Novel compounds | |
SE9901901D0 (sv) | Compounds | |
SE0102640D0 (sv) | Novel compounds | |
SE0403117D0 (sv) | New compounds 1 | |
SE0103325D0 (sv) | Novel compounds | |
SE0202280D0 (sv) | Novel compounds | |
SE0300907D0 (sv) | Novel compounds |